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Periostin is a matricellular protein that is reactivated
during tissue damage and repair and has been
shown to be a critical regulator of multiple biological
pathways involved in the repair of tissue after
myocardial infarction, peripheral vascular disease, and
skin wounds. The tissue repair properties attributed
to periostin make it an ideal candidate to enhance
the therapeutic properties of donor cells such as
mesenchymal stem cells from adipocyte tissue. In
a recent article in Stem Cell Research & Therapy, Qin
et al. demonstrated enhanced therapeutic properties
of adipocyte-derived stem cells by genetically
engineering them to express periostin.modified ADSCs had superior tissue repair propertiesMesenchymal stromal or stem cells (MSCs) from differ-
ent tissue sources have a proven track record of enhan-
cing tissue repair through the direct contribution to new
tissue by engrafting and differentiating into muscle,
endothelial cells, adipocytes, and bone. MSCs also have
a powerful paracrine signaling system resulting in the
enhancement of endogenous repair mechanisms. Despite
the advantages of cell-based therapy, one of the common
problems facing the use of cells for tissue repair is the
low survival rate of the donor cells. In a recent article in
Stem Cell Research & Therapy, Qin et al. modified
adipose-derived stem cells (ADSCs) to improve their
survival [1]. Normally, donor cells are subjected to host* Correspondence: rogers@lunenfeld.ca
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which lead to apoptosis and cell survival rates of less
than 1 % [2]. There have been attempts to overcome
these adverse conditions through the addition of genes,
mRNA, or proteins to modify the donor cells or by
modifying the host environment with the goal of enhan-
cing donor cell survival. Alternatively, cell carriers, in
the form of hydrogels or the addition of extracellular
matrix (ECM) and matricellular proteins that offer both
mechanical and biological support, have demonstrated
enhanced donor cell survival and increased tissue repair
[3–5], but more improvements are still required to meet
the needs of patients.
Qin et al. modified ADSCs to express the periostin
gene by using lentivirus vectors and determined that the
compared with unmodified control ADSCs by using a
model of peripheral vascular disease (PVD) [1]. Periostin
is a matricellular protein that has multiple effects be-
cause of its ability to activate several biological pathways.
Periostin is expressed embryonically but is re-expressed
in adults after tissue damage and during tissue repair.
Because periostin is secreted and is a component of the
ECM, it has a role in inducing cell survival, proliferation,
migration, and adhesion to the ECM. In the context of tis-
sue repair, Qin et al. showed that periostin-secreting
ADSCs had a greater contribution to tissue repair com-
pared with unmodified cells because they survived better
in the hypoxic environment generated by damaged tissue
and were able to engraft and differentiate into endothelial
and muscle cells. Furthermore, the periostin-producing
ADSCs demonstrated an enhancement of their paracrine
signaling-mediated tissue repair mechanism [1].
Tissue repair, whether in the context of PVD [6], skin
wounds [7], spinal cord injury [8], or cardiac ischemia
[9], follows a similar healing process. The initiating eventarticle is distributed under the terms of the Creative Commons Attribution 4.0
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of macrophages to remove cell debris and the infiltration
of neutrophils and fibroblasts. The fibroblasts lay down
new ECM that permits the further migration of cells into
the wound area. Fibrocytes and myofibrocytes remodel
the new ECM, resulting in an organized protein network
that provides a foundation for tissue repair, including
engraftment of MSCs, which can differentiate and con-
tribute to new tissue or induce repair through the induc-
tion of endogenous cells through a paracrine signaling
mechanism [10]. The eventual replacement of fibroblasts
with tissue-appropriate cells results in proper tissue
architecture instead of scar tissue formation. For most
tissue repair situations, the production of scar tissue is
the end result, and tissue remodeling to produce normal
tissue takes years. In older patients or patients with se-
vere tissue damage, the scar tissue may be permanent.
Treatment with exogenous MSCs does result in reduced
scarring because of the enhancement of the tissue repair
process.
Adipose tissue, bone marrow, and umbilical cord tis-
sues are all commonly used sources of MSCs to treat
tissue damage. Qin et al. used ADSCs instead of bone
marrow-derived MSCs, cells which share similar prop-
erties, because adipose tissue collection is minimally
invasive, making them more clinically applicable. Qin
et al. also chose lentivirus to introduce the periostin
gene into the cells. Although the use of lentivirus faces
more stringent safety measures compared with using
other non-permanent methods to modify cells, lentivirus
vectors offer advantages such as stable transfection of the
cells, resulting in long-term periostin production at the
site of cell transplantation. Furthermore, lentiviruses do
not induce an immune reaction in the host, and
lentivirus-modified cells are currently being used in
multiple clinical trials (www.ClinicalTrials.gov). Previ-
ous studies have used non-integrating plasmids to de-
liver genes [11], mRNA transfection [12], or the direct
injection of protein into the damaged tissue, thus
bypassing the use of cells completely [4]. However, both
plasmid and mRNA transfections are inefficient and
have a short half-life, and the direct injection of protein
results in the diffusion and degradation of the protein.
Periostin has a central role in tissue repair, acting at
the nexus of multiple biological pathways. Inflammation
induces transforming growth factor beta 1 (TGFβ1) and
tumor necrosis factor alpha (TNFα), which in turn
regulate critical ECM protein and matricellular pro-
teins, including periostin, heat shock protein (hsp),
and fibronectin [13]. Periostin then activates the
phosphatidylinositol-3-OH kinase (PI3K) pathway and
the downstream kinase Akt. PI3K/Akt signaling regu-
lates several functions, including cell survival, growth,
cycling, and migration [3]. Studies that engineeredMSCs to express AKT [14], PI3K [3], or Hsp [15] con-
firm that all of these proteins have a role in wound
healing. By genetically engineering ADSCs to express
periostin, a central regulator of multiple biological
pathways involved in tissue repair, Qin et al. make an
important advancement in cell therapy that is applic-
able to multiple disease systems besides PVD, such as
myocardial infarction and diabetic skin ulcers [1].
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